Driving the new generation of value-based agreements
Value-based agreements unite pharma companies and payers with a mutually beneficial payment model,...
2 minute read
HealthVerity pulse: Q2 in review
Throughout the past quarter, we’ve announced major collaborations, built on existing partnerships...
2 minute read
HealthVerity Patient Confidence Index (HVPCI) upgraded to Critical as physician visits rise sharply
June 25, 2020 - Philadelphia, PA - HealthVerity announced the biweekly update to its HealthVerity...
2 minute read
HealthVerity Patient Confidence Index (HVPCI) downgraded to Severe as telehealth visits diminish
June 11, 2020 - Philadelphia, PA - HealthVerity announced the biweekly update to its HealthVerity...
2 minute read
HealthVerity Patient Confidence Index (HVPCI) advances to Critical even as telehealth visits plateau
May 28, 2020 - Philadelphia, PA - HealthVerity announced the biweekly update to its HealthVerity...
2 minute read
HVPCI reinforces the severe state of healthcare in America
May 14, 2020 - Philadelphia, PA - HealthVerity announced the biweekly update to its HealthVerity...
2 minute read
Real-time data interoperability in the COVID-19 era
The COVID-19 outbreak has created an unprecedented need for real-time data. As the global pandemic...
2 minute read
Making decisions with real-world evidence and COVID-19
The COVID-19 pandemic has triggered intense and widespread action among the biopharma industry and...
1 minute read
Accelerating the path to regulatory submission with RWD
The use of real-world data (RWD) in pharmaceutical development is becoming increasingly prevalent and the FDA is encouraging its usage, having released guidance “intended to accelerate medical product development and bring innovations faster and more...
- Data ecosystem by:HealthVerity on: July 9, 2020